- Home
- EPSN vs KOD Comparison
EPSN vs KOD Comparison
Compare EPSN & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EPSN | KOD |
|---|---|---|
| Founded | 2005 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.1M | 795.5M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | EPSN | KOD |
|---|---|---|
| Price | $4.57 | $26.11 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $22.67 |
| AVG Volume (30 Days) | 115.2K | ★ 761.8K |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | ★ 5.27% | N/A |
| EPS Growth | ★ 11.33 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $45,709,605.00 | N/A |
| Revenue This Year | $41.35 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $17.73 | ★ N/A |
| Revenue Growth | ★ 46.76 | N/A |
| 52 Week Low | $4.36 | $1.92 |
| 52 Week High | $8.50 | $28.79 |
Technical Indicators
Market Signals| Indicator | EPSN | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 39.92 | 63.54 |
| Support Level | $4.76 | $25.44 |
| Resistance Level | $5.09 | $28.79 |
| Average True Range (ATR) | 0.18 | 1.97 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 1.82 | 63.17 |
Price Performance
Historical ComparisonAbout EPSN Epsilon Energy Ltd.
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.